End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
270.50 TWD | -2.70% | -1.28% | -0.55% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals Segment | 9.11B | 10.54B | 12.53B | 14.5B | 16.86B | |||||
Total Assets | - | - | 21.53B | 29.64B | 32.84B | |||||
Operating Income | 1.06B | 1.58B | 2.29B | 4.11B | 4.87B | |||||
Pharmaceutical Contract Research Organization | ||||||||||
Others | 242M | 259M | 236M | 301M | 339M | |||||
Total Assets | - | - | 440M | 594M | 845M | |||||
Operating Income | 70.34M | 33.82M | 4.96M | 2.48M | 31.23M | |||||
Foreign | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Domestic | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Elimination | -176M | -72.9M | -113M | -171M | -245M | |||||
Total Assets | - | - | -744M | -709M | -697M | |||||
Operating Income | -14.1M | -4.36M | 3.27M | -3.26M | 659K |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 2.69B | 3.23B | 4.45B | 5.92B | 6.81B | |||||
Total Assets | - | - | - | - | 1.27B | |||||
South Korea | 5.04B | 5.11B | 5.25B | 5.28B | 5.59B | |||||
Total Assets | 3.52B | 3.21B | 2.62B | 2.12B | 1.98B | |||||
Taiwan | 826M | 862M | - | - | 2.41B | |||||
Total Assets | 2.13B | 2.62B | 3.59B | 7.74B | 7.54B | |||||
Others | 622M | 1.53B | 2.95B | 3.44B | 2.14B | |||||
Total Assets | 53.96M | 467M | 481M | 788M | 262M |
- Stock Market
- Equities
- 1795 Stock
- Financials Lotus Pharmaceutical Co., Ltd.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition